Your browser doesn't support javascript.
loading
Progress of medicinal plants and their active metabolites in ischemia-reperfusion injury of stroke: a novel therapeutic strategy based on regulation of crosstalk between mitophagy and ferroptosis.
Zhang, Guozhen; Wang, Qiang; Jiang, Bing; Yao, Lihe; Wu, Wenjuan; Zhang, Xiaoyan; Wan, Dongjun; Gu, Youquan.
Afiliação
  • Zhang G; College of the First Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.
  • Wang Q; Department of Neurology, People's Liberation Army Joint Logistics Support Force 940th Hospital, Lanzhou, Gansu, China.
  • Jiang B; Department of Neurology, First Hospital of Lanzhou University, Lanzhou, Gansu, China.
  • Yao L; Department of Integrated Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu, China.
  • Wu W; Department of Neurology, First Hospital of Lanzhou University, Lanzhou, Gansu, China.
  • Zhang X; Department of Neurology, First Hospital of Lanzhou University, Lanzhou, Gansu, China.
  • Wan D; Department of Neurology, People's Liberation Army Joint Logistics Support Force 940th Hospital, Lanzhou, Gansu, China.
  • Gu Y; Department of Neurology, People's Liberation Army Joint Logistics Support Force 940th Hospital, Lanzhou, Gansu, China.
Front Pharmacol ; 15: 1374445, 2024.
Article em En | MEDLINE | ID: mdl-38650626
ABSTRACT
The death of cells can occur through various pathways, including apoptosis, necroptosis, mitophagy, pyroptosis, endoplasmic reticulum stress, oxidative stress, ferroptosis, cuproptosis, and disulfide-driven necrosis. Increasing evidence suggests that mitophagy and ferroptosis play crucial regulatory roles in the development of stroke. In recent years, the incidence of stroke has been gradually increasing, posing a significant threat to human health. Hemorrhagic stroke accounts for only 15% of all strokes, while ischemic stroke is the predominant type, representing 85% of all stroke cases. Ischemic stroke refers to a clinical syndrome characterized by local ischemic-hypoxic necrosis of brain tissue due to various cerebrovascular disorders, leading to rapid onset of corresponding neurological deficits. Currently, specific therapeutic approaches targeting the pathophysiological mechanisms of ischemic brain tissue injury mainly include intravenous thrombolysis and endovascular intervention. Despite some clinical efficacy, these approaches inevitably lead to ischemia-reperfusion injury. Therefore, exploration of treatment options for ischemic stroke remains a challenging task. In light of this background, advancements in targeted therapy for cerebrovascular diseases through mitophagy and ferroptosis offer a new direction for the treatment of such diseases. In this review, we summarize the progress of mitophagy and ferroptosis in regulating ischemia-reperfusion injury in stroke and emphasize their potential molecular mechanisms in the pathogenesis. Importantly, we systematically elucidate the role of medicinal plants and their active metabolites in targeting mitophagy and ferroptosis in ischemia-reperfusion injury in stroke, providing new insights and perspectives for the clinical development of therapeutic drugs for these diseases.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article